tanshinone ii a has been researched along with anisomycin in 2 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (anisomycin) | Trials (anisomycin) | Recent Studies (post-2010) (anisomycin) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 1,357 | 0 | 319 |
| Protein | Taxonomy | tanshinone ii a (IC50) | anisomycin (IC50) |
|---|---|---|---|
| Glucose transporter | Leishmania mexicana | 0.225 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.326 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.321 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
1 review(s) available for tanshinone ii a and anisomycin
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
1 other study(ies) available for tanshinone ii a and anisomycin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |